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Abstract
Background: Neuropathic pain must be correctly diagnosed for optimal treatment. The questionnaire named
Neuropathic Pain Symptom Inventory (NPSI) was developed in its original French version to evaluate the different
symptoms of neuropathic pain. We hypothesized that the NPSI might also be used to differentiate neuropathic
from non-neuropathic pain.
Methods: We translated the NPSI into German using a standard forward-backward translation and administered it
in a case-control design to patients with neuropathic (n = 68) and non-neuropathic pain (headache and
osteoarthritis, n = 169) to validate it and to analyze its discriminant properties, its sensitivity to change, and to
detect neuropathic pain subgroups with distinct profiles.
Results: Using a sum score (the NPSI-G score), we found sensitivity to change (r between 0.37 and 0.5 for pain
items of the graded chronic pain scale) and could distinguish between neuropathic and other pain on a group
basis, but not for individual patients. Post hoc development of a discriminant score with optimized diagnostic
properties to distinguish neuropathic pain from non-neuropathic pain resulted in an instrument with high
sensitivity (91%) and acceptable specificity (70%). We detected six different pain profiles in the patient group with
neuropathic pain; three profiles were found to be distinct.
Conclusions: The NPSI-G potentially combines the properties of a diagnostic tool and an instrument to identify
subtypes of neuropathic pain.
Background
Neuropathic pain must be correctly diagnosed for opti-
mal treatment. Several screening tools have been devel-
oped to differentiate neuropathic from non-neuropathic
pain [1]. These include the Leeds Assessment of Neuro-
pathic Symptoms and Signs (LANSS [2]), the Neuro-
pathic Pain Questionnaire [3], the DN4 [4], the
painDETECT questionnaire [5], and the ID pain [6].
Another goal of pain questionnaires is the use of effec-
tive pain descriptors to identify subgroups of patients
that may benefit from specific therapies. Such question-
naires are the Neuropathic Pain Scale (NPS) [7] and the
Neuropathic Pain Symptom Inventory (NPSI) [8]. The
NPSI has psychometric properties which suggest that it
may be used to characterize subgroups of neuropathic
pain patients and verify whether they respond differen-
tially to treatment [8]. It has good construct validity,
high test-retest reliability, and is sensitive to change. It
has been translated into several languages and used in
clinical trials [9,10]; see additional file 1 for its (non-vali-
dated) English translation by the original authors. Given
the good psychometric properties of the NPSI, we con-
structed and validated a German version, the NPSI-G
with the aims to analyze its sensitivity to change and to
* Correspondence: sommer@uni-wuerzburg.de
† Contributed equally
1Department of Neurology, University of Würzburg, Germany
Full list of author information is available at the end of the article
Sommer et al. BMC Neurology 2011, 11:104
http://www.biomedcentral.com/1471-2377/11/104
© 2011 Sommer et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
identify distinct subgroups among patients with neuro-
pathic pain. We hypothesized that the NPSI might also
be used to differentiate neuropathic from non-neuro-
pathic pain, a distinction which was not tested in the
original study. We collected data from 237 participants
with confirmed neuropathic pain, and with two fre-
quently encountered non-neuropathic chronic pain syn-
dromes, osteoarthritis, or headache. To enhance the
separation qualities of the NPSI-G for neuropathic and
non-neuropathic pain, we used discriminant analysis to
construct a weighted sum score of the variables.
Methods
Patients
Patients with neuropathic pain and headache were
recruited from the Department of Neurology, University
of Würzburg and the Department of Pain Management
(Bergmannsheil), Ruhr University, Bochum. Patients
with osteoarthritis related pain were recruited from the
Department of Orthopedics (König-Ludwig-Haus), Uni-
versity of Würzburg and the Department of Orthopedics
(St. Josefs Klinikum), Ruhr University, Bochum. A diag-
nosis of neuropathic pain was confirmed when asso-
ciated with a definite neurological cause as determined
during routine in- or outpatient management of the
patient. In addition, it was required that the pattern of
pain distribution was characteristic of the respective
diagnosis. Headache was diagnosed using the Interna-
tional Headache Society criteria for tension type head-
ache and migraine [11]. Only patients with a headache
present at the time of visit were included. Headache was
chosen in order to have a pain condition with a very dif-
ferent distribution from that in most patients with neu-
ropathic pain. Osteoarthritis was diagnosed based on
criteria provided by the American College of Rheuma-
tology (http://www.rheumatology.org). Osteoarthritis
was chosen to include a condition that (like in most
patients with neuropathic pain in our sample) entails
pain in the extremities. Exclusion criteria were coexis-
tence of several conditions possibly causing pain, severe
depression, chronic alcoholism or substance abuse, and
an inability to understand the questionnaire. Patients
with neuropathic pain received current symptomatic
treatment, including analgesic drugs, when admitted or
seen as outpatients.
NPSI Translation into German and adaptation of the NPSI
for patients with headache and osteoarthritis
Using the original French NPSI, we used a standard for-
ward-back translation to develop the German equiva-
lent. First, two translators who were native French
speakers and fluent in German (one with, one without
medical knowledge) translated the questionnaire into
German. A reconciled language version was developed
using these two forward translations. A third profes-
sional translator (a native German speaker fluent in
French) produced the back-translation. The final version
was evaluated by three independent medical profes-
sionals fluent in both French and German usage. Discre-
pancies in wording were analyzed and when required,
resolutions were obtained by consensus. A diagram
depicting pain attacks and episodes of continuous pain
was inserted to facilitate patient comprehension. For
quality control, patients were instructed to indicate
areas of pain on an additional diagram (see additional
file 2 for a full version of the NPSI-G). Patients with
headache or osteoarthritis related pain were additionally
required to complete a short questionnaire that
addressed aspects of their headache (questions were
designed to differentiate between tension headaches and
migraines) or, their joint pain (location of pain sites
including potentially related sites).
Study design
The study was approved by the Ethics Committees of the
Universities of Bochum and Würzburg. After providing
informed consent, the patients were required to complete
four questionnaires: the NPSI-G, the German version of
the NPS (NPS-D), the graded chronic pain scale (GCPS,
[12]), and the German version of the Center for Epide-
miologic Studies Depression Scale (CES-D) [13]. Patients
diagnosed with neuropathic pain were instructed to com-
plete a 2nd NPSI-G as well as the patient global impres-
sion of change (PGIC) scale [14] 24 hours later. The
entire set of questionnaires was repeated at 4 weeks.
Since most of these patients were inpatients, their 24
hour questionnaire was readily distributed and collected.
Outpatients with neuropathic pain were given both the
24 hour and 4 week questionnaires with dates for com-
pletion clearly marked and prepaid postal envelopes
addressed to the investigators. Patients who did not
return the questionnaires at the specified time intervals
received telephone reminders. During the 4-week period,
patients underwent medical treatment as required.
Patients with headache (mostly outpatients) or osteoar-
thritis pain (mostly inpatients) received all of the above
questionnaires only once and were instructed to com-
plete their questionnaires while at the hospital.
Depressive symptoms were assessed using the CES-D
questionnaire. Scores above 23 points were considered
indicative of depressive states. Pain intensities were graded
using the 11-point numerical scales (0 - 10) of the GCPS.
Sample description and comparison of the diagnostic
groups
Sample description included diagnostic data, age,
gender, depression score (CES-D) and general pain char-
acteristics (GCPS scores) for each diagnostic group.
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Construction of a score for assessing neuropathic pain
A sum score (NPSI-G score) for assessing the severity of
neuropathic pain was calculated using the sum score
methodology of our reference study [8]. A possible posi-
tive contribution of the categorical items Q4 (frequency
of spontaneous pain) and Q7 (number of pain attacks)
to the score was examined by transforming them into
dichotomous variables and post hoc adding weighted
variable scores to the sum score. Then we looked for
improvement by comparing the validity measures of the
original and the expanded score. Optimized transforma-
tion rules and weight-coefficients were generated from
an algorithm which tested possible improvements of the
correlations in the validity calculations.
Reliability and validity of the NPSI-D
For the group of patients with neuropathic pain, we
assessed the test-retest reliability of the NPSI-G and the
NPSIG score and analyzed its convergent and divergent
validities. The test-retest reliability of the interval-scaled
items and the NPSI-G score was assessed by calculating
intra-class correlations (ICC, two way random model)
for all items included in the initial measurements and
the 24-hour follow-up. Since there are no validated
instruments available in German comparable to the
NPSI, we used two widely employed comparators for
convergent validity; the German version of the NPS [7]
(NPS-D) and those items from the GCPS that examine
intensity of pain (current, average and maximal pain
assessments over the 4 week interval). Divergent validity
was measured by calculating the Pearson correlations
with the CES-D scores. We then compared the reliabil-
ity of the NPSI-G items and the NPSI-G score with the
French reference study.
Sensitivity to change
The Pearson correlations between the 4-week change of
the NPSI-G score and the changes of current, average,
and maximum pain in the GCPS, the PGIC-score, and
the change of the CES-D-score were calculated in
patients with neuropathic pain, whereby the CES-D was
used as a control measure for divergent characteristics.
Correlations were considered low, medium or high as
they reached levels of r = 0.1, r = 0.3, or r = 0.5 respec-
tively [15]. To conclude that there was sensitivity to
change, we would expect at least medium correlations
with the changes of pain intensity in the CGPS (r ≥ 0.3).
As the PGIC score is a gross estimate of changes in
pain intensity, it was only considered as an additional
control instrument. A low to medium correlation (r ≥
0.2) was judged sufficient to support the hypothesis that
the NPSI-G score is sensitive to change. Low correla-
tions with the ASD-score (r < 0.3) would support diver-
gent validity.
Evaluation of the discriminant properties of the NPSI-G
and the NPSI-G score
Responses to the NPSI-G items were compared between
the diagnostic groups by analyzing the mean values and
the frequencies of positive item responses (values > 0),
indicating the occurrence of the different qualities of
pain for the 10 interval scaled items Q1 - Q3, Q5 - Q6,
Q8 - Q12. Mean values of items and sum score were
calculated and compared between diagnostic groups.
The distribution of the NPSI-G score within the groups
was analyzed using box plots. The correlation of the
NPSI-G score with age, sex, pain intensity in the CGPS,
and the CES-D score was calculated by Pearson correla-
tions to control for a possible bias caused by between-
group differences of these parameters. We then exam-
ined the diagnostic power of the NPSI-G score using a
receiver operating characteristic (ROC) diagram [16].
The ROC diagram shows the possible combinations of
sensitivity and specificity that can be achieved for a
given score. The non-neuropathic group was formed by
combining the osteoarthritis and the headache patients.
Development and analysis of a diagnostic tool
based on the NPSI-G
To develop a tool that would separate patients with
neuropathic pain from the other groups, we calculated a
discriminant score (NPSI-G-dis) using discriminant ana-
lysis. This weighted sum score of the variables was con-
structed using specific coefficients for each variable to
allow optimal separation of the different diagnostic
groups. We used all variables from the NPSI-G includ-
ing the two categorical variables Q4 and Q7, which
were transformed into dichotomous variables similar to
the construction described in the definition of the
NPSI-G score, but without weight coefficients which
were dispensable in this context. In this case an optimal
ROC-diagram was the criterion for an appropriate
transformation.
Analysis of different pain profiles in patients with
neuropathic pain
Using a cluster analysis (hierarchical Ward analysis [17]
with follow up k-means analysis) based on the ten inter-
val items of the NPSI-G, we looked for subgroups with
different pain profiles within the neuropathic pain
group. Profiles were compared by multivariate variance
analysis (MANOVA; Wilks-Lambda used as test statis-
tic) and differences between the item scores within each
cluster by variance analysis for dependent measures. An
analysis of current and maximal pain levels from the
GCPS was done to evaluate whether clusters were based
on pain severity only. The distribution of pain intensities
was examined by box plots; mean values for different
clusters were compared by t-tests.
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Test statistics and measurements of coherence
In addition to the already described methods, we used
the following statistical tests: Frequencies of item
responses were compared using Chi-square tests. Com-
parison of group means (of the different diagnostic
groups or of groups defined by the results of the cluster
analysis) was done by t-tests in the case of two groups
and by ANOVAs with post hoc tests (Sidak resp. Dun-
nett T-3 adjustments for multiple testing) when more
than two independent groups were involved [18,19]. To
analyze coherence of item responses, we calculated
Pearson correlations. Compensation for multiple com-
parisons was done by Bonferroni adjustments [20].
Results
Sample description and comparison of the diagnostic
groups
Out of 255 patients screened, we recruited 241 partici-
pants who fulfilled the inclusion criteria. Four patients
(n = 2 with osteoarthritis and headache each) were later
excluded from analysis because of failure to complete
the NPSI-questionnaire. The study cohort consisted of
the remaining 237 patients. Patient data are provided in
Table 1. The mean age of patients with neuropathic
pain and with osteoarthritis was nearly the same (p =
0.88) whereas headache patients were younger (p <
0.001 for either comparison). There were fewer women
in the neuropathic pain group (p < 0.05 for the overall
comparison). Pain intensities from the GCPS differed
between the three diagnostic groups (see Table 1, p <
0.05 for all items in the overall tests). Fewer patients
with osteoarthritis had depressive symptoms than
patients in the other diagnostic groups (p < 0.01).
The NPSI-G score
Cronbach’s alpha for the 10 interval items (a = 0.75)
allowed accepting a one dimensional latent construct
and thus calculating a sum score [21,22], the NPSI-G
score. This calculation was different from the algo-
rithm used in the reference study, where the authors
had extracted a 5-dimensional factor solution leading
to sub-scores for each dimension, which were then
added to obtain an overall sum score. The inclusion of
the transformed categorical items Q4 and Q7 did not
lead to remarkable improvements of the correlations
shown in Table 2; in most cases, correlations were
even lower. The best result was a gain of 0.02 points
for the correlation with average pain. Thus, the origi-
nal NPSI-G score was retained with the exclusion of
items Q4 and Q7.
Table 1 Demographic and clinical data of the study participants
Clinical and demographic data Diagnosis
NP OA H all
N 68 93 76 237
mean age 59.1 ± 13.0 60.5 ± 12.4 49.7 ± 14.7 56.6 ± 14.1
(range) (26-85) (22-83) (20-83) (20-85)
Sex (%women) 35.3 52.2 55.4 48.3
mean pain intensity on a numeric 0-10 - pain scale (SD)
current pain 4.9 (2.8) 5.5 (2.8) 4.1 (3.0) 4.9 (2.9)
maximal pain intensity in the past 4 weeks 8.1 (1.8) 6.8 (2.6) 7.8 (2.2) 7.5 (2.3)
average pain intensity in the past 4 weeks 6.1 (2.1) 6.2 (2.6) 5.3 (2.3) 5.9 (2.4)
Diagnosis N (%)
CES-D≥23 CES-D <23 all
NP 25 (42) 34 (58) 68 (29)
central pain 8 (11)
nerve injury pain 10 (15)
peripheral neuropathy 50 (74)
OA 15 (18) 70 (82) 93 (39)
gonarthritis 39 (42)
coxarthritis 26 (28)
others 28 (30)
H 30 (41) 44 (59) 76 (32)
migraine 58 (76)
tension headache 18 (24)
all 70 (30) 148 (70) 237 (100)
NP: Neuropathic pain; OA: osteoarthritis; H: headache; depr: depressive
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Reliability and validity
The test-retest reliabilities for a 24 h time interval are
shown in Table 3. Only four items obtained an ICC
higher than 0.80, with one item (burning) having an
ICC of only 0.66. Despite this restricted stability on the
item level, the NPSI-G score was highly reliable (ICC =
0.89) which is comparable to the sum score of the refer-
ence study (ICC = 0.94).
Construct validity information is given in Table 3. The
correlation of the NPSI-G score with the NPS-D score
was high. As expected, the correlation with current pain
intensity in the GCPS was also high in contrast to med-
ium correlations with maximum pain and average pain
in the past 4 weeks. The correlation with the depres-
sion-score was low and supported divergent validity.
Sensitivity to change
The Pearson correlations for a 4-week change in the
NPSI-G score, a parallel change in the GCPS and the
PGIC are shown in Table 4. As expected, we found
medium to high correlations with changes of current
pain and average pain (r-values nearly 0.5) and a med-
ium correlation with maximal pain. Correlations with
the PGIC were low to medium (nearly 0.3). Divergent
validity was shown by the low correlation with changes
in the CES-D.
Evaluation of the discriminant properties of the NPSI-G
The pain drawings confirmed that the pain the patients
described was directly related to the syndrome they
were initially diagnosed with: headache patients loca-
lized their pain to the head, the osteoarthritis patients
to the respective joints, and the patients with neuro-
pathic pain to their feet or the area of their nerve
lesion. Table 5 shows the characteristics of the item
responses for the different diagnostic groups. A ten-
dency for a higher number of positive answers was
observed in the neuropathic pain group. Mean values
for neuropathic pain patients however, only signifi-
cantly exceeded those in the other diagnostic groups
for the items “burning pain”, “pins and needles”, and
“tingling”.
When we calculated the NPSI-G scores for the differ-
ent diagnostic groups, the mean value for neuropathic
pain patients was significantly higher than that of the
comparison groups (p < 0.05 for both comparisons with
neuropathic pain, adjusted a). There was no significant
difference between the two comparison groups (p >
0.98). In spite of these findings, the box plots in Figure
1 demonstrate a wide overlap which indicates a poor
separation quality of the NPSI-G score. This was con-
firmed by the ROC diagram (Figure 2), which demon-
strated only unacceptable combinations of sensitivity/
specificity.
Construction and analysis of a diagnostic tool based on
the NPSI-G
Since the separation quality of the NPSI-G score for
neuropathic versus non-neuropathic pain was not satis-
factory, we used discriminant analysis to construct an
improved score for the separation of neuropathic and
non-neuropathic pain. The optimal transformations of
the categorical items 4 and 7 into dichotomous scores
are: Q4_d = 0/1 if Q 4 ≥ 4/<4; Q7_d = 0/1 if Q7 ≥2/<2
(allocation of higher scores to lower class numbers
corresponds to the order of classes in the questionnaire,
smaller numbers indicate higher numbers of
complaints).
The resulting post-hoc discriminant score (NPSI-G-
dis) is calculated by the coefficients given in Table 6,
using them as weight factors for the item scores.
Table 2 Intraclass correlation coefficients (ICC) for each
item and for the NPSI sum scores based on baseline and
second measurement (after 24 h in the current study and
after 3 h in the reference study)
Current study Reference study
Burning 0.66 0.95
Squeezing 0.82 0.91
Pressure 0.75 0.98
Electric shocks 0.95 0.90
Stabbing 0.79 0.92
Evoked by brushing 0.70 0.97
Evoked by pressure 0.72 0.95
Evoked by cold stimuli 0.79 0.88
Pins and needles 0.84 0.98
Tingling 0.84 0.87
Sum score 0.89 0.94
Table 3 Convergent and divergent validities (Pearson
correlations) for patients with neuropathic pain
correlation with NPSI-D score
NPS-D score 0.87
current pain 0.69
maximal pain (past 4 weeks) 0.42
average pain (past 4 weeks) 0.41
CES-D-score 0.14
Table 4 Correlation of changes in a 4-week period in
patients with neuropathic pain (Pearson correlations)
NPSI-D
current pain 0.46
maximal pain (past 4 weeks) 0.39
average pain (past 4 weeks) 0.49
PGIC 0.28
CES-D 0.23
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To obtain a flexible diagnostic instrument, appropriate
cut-off values need to be chosen. Figure 3 shows the
possible combinations of sensitivity and specificity for
the NPSI-G-dis. Some possible value pairs for sensitiv-
ity/specificity are (cut-off values in brackets): 91%/70%
(49.0), 80%/82% (53.5) or 72%/90% (58.0). The discrimi-
nant score led to a clear improvement of diagnostic
quality compared to the sum score which can be seen in
the ROC diagram (Figure 2). The correlations of the
NPSI-G-dis with group parameters were low to negligi-
ble: r = 0.11/0.05/0.15 for current pain/average pain/
maximal pain from the GCPS, p = 0.17/0.52/0.053 and r
= 0.11/0.22/0.21 for age/gender/depression, p = 0.16/
0.003/0.005.
Pain profiles of neuropathic pain patients
The cluster analysis led to a six-cluster solution (Figure
4). Comparing the profiles by multivariate variance ana-
lysis led to a significant result for the overall analysis (p
< 0.001). Using pairwise testing (with Bonferroni adjust-
ment for 15 comparisons, a = 0.05 as target), the profile
of cluster 1 was different from all other clusters.
Furthermore, the profile of cluster 2 was different from
the clusters 4 and 5. Three of the profiles, the clusters
1, 2, and 5 (n1 = 16, n2 = 10, n5 = 9), were mutually dif-
ferent with statistical significance. The differences
between cluster 1 and 2 or between cluster 2 and 5
were due to different shapes and not to different levels
alone. Clusters 1 and 2 were different for the items
“pins and needles” and “tingling” (p < 0.001 for both
comparisons) whereas all other differences may be
neglected (p > 0.27 for all cases). A comparison of clus-
ter 2 and 5 led to the opposite result, with no difference
in the items “pins and needles” and “tingling” (p = 0.180
resp. p = 0.774) but significant differences for all other
items (p < 0.015 for each case). Cluster 1 and 5 were
similar in shape but with different levels of values. To
control for the influence of global pain intensity on the
differences between clusters, we show in Figure 5 the
distribution of the pain intensities according to the
CGPS in each cluster. For example there were no differ-
ences between the pain intensities of cluster 1 and 2
thus indicating that differences in profiles cannot be
attributed to differences in pain intensities alone.
Table 5 Frequency of positive NPSI item responses
NP OA p
(NP vs. OA)
H p
(NP vs. H)
reference study#
Burning 73.4 31.9 < 0.001* 30.8 < 0.001* 70.5
Squeezing 50.8 24.3 0.001* 53.1 0.859 63.4
Pressure 64.4 67.0 0.857 87.5 0.003* 60.6
Electric shocks 42.6 21.9 0.010* 42.2 1.000 61.2
Stabbing 68.8 68.9 1.000 61.6 0.468 60.1
Evoked by brushing 31.1 36.4 0.596 15.9 0.040* 68.5
Evoked by pressure 62.5 62.9 1.000 38.0 0.006* 67.5
Evoked by cold 29.5 17.9 0.114 27.7 0.849 42.5
Pins and needles 77.7 26.1 < 0.001* 35.6 < 0.001* 63.0
Tingling 52.3 26.4 < 0.001* 30.5 0.014* 66.4
Means for item and sum
scores (SD)
NP OA p
(NP vs. OA)
H p
(NP vs. H)
all
Burning 4.7 (3.4) 2.0 (3.3) < 0.001* 1.8 (2.8) < 0.001* 2.8 (3.4)
Squeezing 3.3 (3.6) 1.4 (2.7) < 0.001* 3.2 (3.4) 0.804 2.5 (3.3)
Pressure 3.7 (3.2) 4.0 (3.4) 0.697 5.4 (3.2) 0.004* 4.4 (3.4)
Electric shocks 2.6 (3.4) 1.4 (2.9) 0.026* 2.1 (3.1) 0.396 2.0 (3.1)
Stabbing 4.5 (3.6) 4.4 (3.5) 0.924 4.1 (3.8) 0.543 4.3 (3.6)
Evoked by brushing 1.7 (3.7) 2.1 (3.6) 0.401 0.9 (3.3) 0.110 1.6 (3.6)
Evoked by pressure 4.0 (3.7) 4.1 (3.6) 0.957 2.2 (3.3) 0.003* 3.5 (3.6)
Evoked by cold 1.7 (2.9) 1.0 (2.4) 0.111 1.4 (2.6) 0.460 1.3 (2.6)
Pins and needles 4.4 (3.2) 1.2 (2.3) < 0.001* 1.5 (2.4) < 0.001* 2.2 (2.9)
Tingling 3.3 (3.5) 1.3 (2.4) < 0.001* 1.3 (2.4) < 0.001* 1.9 (2.9)
33.2 22.5 22.5
Sum score (19.5) (14.1) < 0.001* (14.1) < 0.001*
NP: Neuropathic pain; OA: osteoarthritis; H: headache; depr: depressive *: p < 0.05
#: frequencies for neuropathic pain patients in the French reference study [8].
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Discussion
Reliability and validity of the NPSI and comparison of the
item characteristics to the French original and to
transnational results
The NPSI-G score demonstrated a high test-retest relia-
bility and convergent as well as divergent construct
validity when applied to neuropathic pain patients. This
allows us to conclude that the NPSI-G is a useful and
reliable instrument for assessing the severity of neuro-
pathic pain. However, since our patient population was
biased toward neuropathic pain of peripheral origin, the
NPSI-G will have to be validated in a separate sample
including also patients with other neuropathic pain syn-
dromes, e.g. with central pain. Nearly all properties of
the NPSI-G score were comparable to the original
French results. In contrast to the reference study, test-
retest-reliability on a per item basis did not reach accep-
table values in all cases. This might possibly be
Figure 1 NPSI-G score for different syndromes. The box plots
show medians and ranges, the whiskers mark the first and the
fourth quartiles. Outliers with a distance from the median that
exceeds three times the box length are excluded. Differences
between neuropathic pain and the other diagnoses are statistically
significant (both p < 0.05).
Figure 2 ROC-curves for the discriminant score NPSI-G-dis and
the NPSI-G score. The graphs show the possible combinations of
sensitivity/specificity values that can be achieved by varying the cut-
off values for each score.
Table 6 Discrimination-coefficients for the discrimination
score
Item Coefficient
Q1: burning 1.8
Q2: squeezing 1.0
Q3: pressure -0.6
Q4_d: spontaneous pain (dichot.)* 0.4
Q5: electric shocks -0.3
Q6: stabbing -0.7
Q7_d: pain attacks (dichot.)* -8.0
Q8: evoked by brushing -0.5
Q9: evoked by pressure 0.5
Q10: evoked by cold stimuli -0.6
Q11: pins and needles 3.7
Q12: tingling -1.3
constant value 50.0
* Q4 and Q7 are dichotomized by setting Q4_d = 1 if Q4<4
resp. Q7_d = 1 if Q7<2 and appointing 0 in the other cases
Figure 3 Sensitivity and specificity achieved for the
discriminant score as a function of the chosen cut-off values.
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attributed to the different time lags, which were 24 h in
the current as opposed to 3 h in the reference study.
The possibility of different connotations of some items
in the respective languages as another possibility for
divergent results has recently been discussed for several
non-validated translations of the NPSI [9]. For neuro-
pathic pain patients, the responder rates for individual
items were more variable than in the French study (see
Table 5). Ranking the items according to responder
rates of neuropathic pain patients resulted in pins and
needles as the most frequently endorsed item, followed
by burning, stabbing and pressure/evoked by pressure.
The other items clearly achieved lower percentages. The
differences in item ranking between the German and
the French study may be caused by the composition of
the neuropathic pain group. While our group consisted
of a majority of patients with peripheral neuropathy,
there were more patients with nerve trauma and with
central pain in the French study which may explain the
higher prevalence of brush evoked and electric shock
like pain in their sample. A recent multinational study
[9] found that across different cultures and languages
Figure 4 Results of a cluster analysis for patients with neuropathic pain. The graph shows mean values and 95% confidential intervals of
item responses for a 6-cluster solution. The profiles of clusters 1, 2 and 5 are mutually different with statistical significance (p < 0.05 after
adjustment for multiple comparisons). x-axis: numerical rating scale (NRS), pain intensity on a 11-point numerical rating scale (0 - 10).
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(German not included), the ranking was the same for
the items with the highest frequency of positive answers:
“pins and needles”, “burning” and “electric shock like”.
This is similar to our results, except for the third item
which was “stabbing” in our study. However, the diag-
nostic composition within groups from the participating
countries varied greatly, and numbers of participants
from each country were small such that direct compari-
sons with the German and the French cohort are diffi-
cult, not excluding further limitations inherent in cross-
cultural comparisons [22].
The correlation with data from the CGPS for current
pain was high, for pain in the last 4 weeks it was only
medium high (see Table 3). This result was predictable
because the NPSI-G asks for current pain symptoms
only. In the reference study, there was a correlation of r
= 0.6 for the NPSI with general pain, comparable to our
result for current pain (see Table 3). The low correlation
with a depression scale was equivalent to the French
study (r = 0.32).
Sensitivity to change
The NPSI-G score is sensitive to change and thus allows
measurement of treatment efficacy. As expected, there
was only a weak correlation between the patients’
assessment of change using the PGIC at 4 weeks and
the NPSI-G score at 4 weeks. In this analysis, the
patients’ assessment of change over a relatively long
period of time was compared with the difference
between two assessments of current symptoms 4 weeks
apart. From a psychological point of view, this analysis
would not be expected to demonstrate strongly corre-
lated results [23].
Discriminant properties of the NPSI-G
The group of patients with neuropathic pain had a typi-
cal profile of pain descriptors that differed significantly
from the control groups with osteoarthritis and head-
ache (see Table 5). Similar group differences were
achieved using the NPSI-G score. The NPSI-G score
however, lacks discriminant power when used for indivi-
dual patients, as demonstrated in Figure 1 and in the
ROC diagram (Figure 2).
The NPSI-G as a tool for diagnosing neuropathic pain
The post hoc construction of a discriminant score based
on the algorithm of discriminant analysis led to clearly
enhanced separation qualities. For example, a high sen-
sitivity of 91% combined with a tolerable specificity of
70% or a combination of 72% sensitivity and 90% speci-
ficity were possible. The quality of this diagnostic instru-
ment is slightly inferior to the diagnostic tool based on
the French DN4 questionnaire (sensitivity 82.9%, specifi-
city 89.9%) [4], which was constructed with a selection
of items from the NPSI and some additional items.
The NPSI-G as a tool for analyzing distinct neuropathic
pain profiles
The cluster analysis revealed six clusters with different
patterns. Three of them (clusters 1, 2, and 5 in Figure 4)
showed differences in pairwise comparisons that were
statistically significant in multivariate testing. Compar-
able patterns but different levels of pain intensity were
found in two clusters (clusters 1 and 5), whereas cluster
2 demonstrated a different shape mainly caused by the
dysesthesia items. Overall, the clusters do not merely
represent distinctive pain intensities as shown by the
box plots in Figure 5, and the different profiles cannot
be explained by different pain levels alone. For example,
clusters 3 to 6 are very similar in pain levels yet show
very different profiles. Most of these differences are sta-
tistically significant in simple comparisons. Whether the
clusters have a clinical meaning regarding pathophysiol-
ogy or response to treatment cannot be answered by
our study. Additional studies with larger numbers of
participants are required to confirm our results. Further-
more, we will need to examine whether the clusters
represent different underlying pain mechanisms.
Limitations of the study
There are several limitations to our study. Limitations in
assessing test-retest reliability must be considered as
Figure 5 Box plots for current pain and maximal pain. The box
plots show current pain and maximal pain in the past 4 weeks in
each of the 6 subgroups of neuropathic pain patients found by
cluster analysis. NRS: pain intensity on a 11-point numerical rating
scale.
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even a latency period of 24 h may be too short to guar-
antee independent measurements.
It was difficult to assess reliability because other pro-
cedures (for example parallel measuring) were not possi-
ble, and with any latency longer than 24 h, influences of
treatment or spontaneous fluctuations in pain character-
istics that would disturb identical conditions for the
responses to the items would have to be expected.
Given the high number of statistical tests, some spur-
iously random results cannot be excluded with certainty.
The discriminant function was optimized for the given
data, and we did not crossvalidate the results. Crossvali-
dation was not possible because of the relatively small
sample size. Our results indicate that a follow-up study
to achieve this aim might be worthwhile. Differences in
group parameters (depressiveness, age, gender, pain
intensity) may have caused some biases when analyzing
group differences. This mainly concerns responses to
single items or the NPSI-G score. The correlations of
this score (calculated for the whole sample) with age
and gender are low, but are considerable for the pain
variables (about 0.5) and for depressiveness (> 0.3). The
discriminant score NPSI-G-dis was only marginally
influenced by these parameters, with only low
correlations.
Conclusions
The NPSI-G is the first questionnaire that is capable of
discriminating subtypes of neuropathic pain and pro-
vides additional information as a diagnostic tool. Using
specifically constructed scores, the NPSI-G can distin-
guish neuropathic from non-neuropathic pain with high
sensitivity and acceptable specificity. This combination
of properties suggests that it may be ideally suited for
use in clinical trials. Further studies with larger numbers
of participants are required to confirm our findings.
Additional material
Additional file 1: English translation of the original NPSI by
Bouhassira et al. (2004). This is not a not a back translated and
validated version of the NPSI, do not use! The English translation is only
given for the benefit of those readers who do not read German or
French.
Additional file 2: Full version of the NPSI-G as it was used in the
study.
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